Postoperative long term chemotherapy for advanced gastric cancer.
A postoperative long term chemotherapy was carried out against stage IV gastric cancer with Mitomycin-C, Futraful and a plant polysaccharide, PS-K. The 2-year survival rate was 15 per cent in patients who received an intraoperative Mitomycin-C alone, while it increased to 34 per cent in those receiving the anticancer agents for a prolonged period. The postoperative long term chemotherapy is assumed to be an effective means of improving the therapeutical results of gastric cancer.
D006801:Humans; D008134:Long-Term Care; D008937:Mitomycins / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D011182:Postoperative Care; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005641:Tegafur / Q000627:therapeutic use
D008937:Mitomycins; D011134:Polysaccharides; D005641:Tegafur